Huvap vapaliximab: Phase I

BTT1V started a U.K. Phase I study of Huvap in 36 healthy volunteers. Huvap was developed in collaboration with Cambridge University and the University of Turku. Boehringer Ingelheim GmbH (Ingelheim,...